Efficacy and Safety of a Human Monoclonal Anti-FGF23 Antibody (KRN23) in Cumulative 4-Month Dose Escalation (KRN23-INT-001) and 12-Month Long-Term Extension Study (KRN23-INT-002) in Adult Subjects with X-Linked Hypophosphatemia (XLH)
JOURNAL OF BONE AND MINERAL RESEARCH（2014）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined